210 related articles for article (PubMed ID: 26878132)
1. Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification.
Takeuchi A; Kobayashi A; Parchi P; Yamada M; Morita M; Uno S; Kitamoto T
Lab Invest; 2016 May; 96(5):581-7. PubMed ID: 26878132
[TBL] [Abstract][Full Text] [Related]
2. A traceback phenomenon can reveal the origin of prion infection.
Kobayashi A; Asano M; Mohri S; Kitamoto T
Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941
[TBL] [Abstract][Full Text] [Related]
3. Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology?
Kobayashi A; Parchi P; Yamada M; Brown P; Saverioni D; Matsuura Y; Takeuchi A; Mohri S; Kitamoto T
J Virol; 2015 Apr; 89(7):3939-46. PubMed ID: 25609817
[TBL] [Abstract][Full Text] [Related]
4. Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures.
Cassard H; Huor A; Espinosa JC; Douet JY; Lugan S; Aron N; Vilette D; Delisle MB; Marín-Moreno A; Peran P; Beringue V; Torres JM; Ironside JW; Andreoletti O
mBio; 2020 Jun; 11(3):. PubMed ID: 32546613
[TBL] [Abstract][Full Text] [Related]
5. Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease creates a new prion strain.
Kobayashi A; Asano M; Mohri S; Kitamoto T
J Biol Chem; 2007 Oct; 282(41):30022-8. PubMed ID: 17709374
[TBL] [Abstract][Full Text] [Related]
6. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.
Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T
Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818
[TBL] [Abstract][Full Text] [Related]
7. Distinct origins of dura mater graft-associated Creutzfeldt-Jakob disease: past and future problems.
Kobayashi A; Matsuura Y; Mohri S; Kitamoto T
Acta Neuropathol Commun; 2014 Mar; 2():32. PubMed ID: 24685293
[TBL] [Abstract][Full Text] [Related]
8. Association of an 11-12 kDa protease-resistant prion protein fragment with subtypes of dura graft-associated Creutzfeldt-Jakob disease and other prion diseases.
Satoh K; Muramoto T; Tanaka T; Kitamoto N; Ironside JW; Nagashima K; Yamada M; Sato T; Mohri S; Kitamoto T
J Gen Virol; 2003 Oct; 84(Pt 10):2885-2893. PubMed ID: 13679624
[TBL] [Abstract][Full Text] [Related]
9. Sporadic Creutzfeldt-Jakob Disease MM1+2C and MM1 are Identical in Transmission Properties.
Kobayashi A; Matsuura Y; Iwaki T; Iwasaki Y; Yoshida M; Takahashi H; Murayama S; Takao M; Kato S; Yamada M; Mohri S; Kitamoto T
Brain Pathol; 2016 Jan; 26(1):95-101. PubMed ID: 25851836
[TBL] [Abstract][Full Text] [Related]
10. Sensitive protein misfolding cyclic amplification of sporadic Creutzfeldt-Jakob disease prions is strongly seed and substrate dependent.
Bélondrade M; Nicot S; Mayran C; Bruyere-Ostells L; Almela F; Di Bari MA; Levavasseur E; Watts JC; Fournier-Wirth C; Lehmann S; Haïk S; Nonno R; Bougard D
Sci Rep; 2021 Feb; 11(1):4058. PubMed ID: 33603091
[TBL] [Abstract][Full Text] [Related]
11. Atypical Creutzfeldt-Jakob disease with PrP-amyloid plaques in white matter: molecular characterization and transmission to bank voles show the M1 strain signature.
Rossi M; Saverioni D; Di Bari M; Baiardi S; Lemstra AW; Pirisinu L; Capellari S; Rozemuller A; Nonno R; Parchi P
Acta Neuropathol Commun; 2017 Nov; 5(1):87. PubMed ID: 29169405
[TBL] [Abstract][Full Text] [Related]
12. Dura mater graft-associated Creutzfeldt-Jakob disease in Japan: clinicopathological and molecular characterization of the two distinct subtypes.
Yamada M; Noguchi-Shinohara M; Hamaguchi T; Nozaki I; Kitamoto T; Sato T; Nakamura Y; Mizusawa H
Neuropathology; 2009 Oct; 29(5):609-18. PubMed ID: 19659940
[TBL] [Abstract][Full Text] [Related]
13. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
[TBL] [Abstract][Full Text] [Related]
14. Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease.
Gelpi E; Baiardi S; Nos C; Dellavalle S; Aldecoa I; Ruiz-Garcia R; Ispierto L; Escudero D; Casado V; Barranco E; Boltes A; Molina-Porcel L; Bargalló N; Rossi M; Mammana A; Tiple D; Vaianella L; Stoegmann E; Simonitsch-Klupp I; Kasprian G; Klotz S; Höftberger R; Budka H; Kovacs GG; Ferrer I; Capellari S; Sanchez-Valle R; Parchi P
Acta Neuropathol Commun; 2022 Aug; 10(1):114. PubMed ID: 35978418
[TBL] [Abstract][Full Text] [Related]
15. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification.
Camacho MV; Telling G; Kong Q; Gambetti P; Notari S
Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic diversity of genetic Creutzfeldt-Jakob disease: a histo-molecular-based classification.
Baiardi S; Rossi M; Mammana A; Appleby BS; Barria MA; Calì I; Gambetti P; Gelpi E; Giese A; Ghetti B; Herms J; Ladogana A; Mikol J; Pal S; Ritchie DL; Ruf V; Windl O; Capellari S; Parchi P
Acta Neuropathol; 2021 Oct; 142(4):707-728. PubMed ID: 34324063
[TBL] [Abstract][Full Text] [Related]
17. Unique clinicopathological features and PrP profiles in the first autopsied case of dura mater graft-associated Creutzfeldt-Jakob disease with codon 219 lysine allele observed in Japanese population.
Ikawa M; Yoneda M; Matsunaga A; Nakagawa H; Kazama-Suzuki A; Miyashita N; Naiki H; Kitamoto T; Kuriyama M
J Neurol Sci; 2009 Oct; 285(1-2):265-7. PubMed ID: 19666177
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of Methionine/Valine Variant Creutzfeldt-Jakob Disease by Protein Misfolding Cyclic Amplification.
Bougard D; Bélondrade M; Mayran C; Bruyère-Ostells L; Lehmann S; Fournier-Wirth C; Knight RS; Will RG; Green AJE
Emerg Infect Dis; 2018 Jul; 24(7):1364-1366. PubMed ID: 29912702
[TBL] [Abstract][Full Text] [Related]
19. Novel histotypes of sporadic Creutzfeldt-Jakob disease linked to 129MV genotype.
Cracco L; Puoti G; Cornacchia A; Glisic K; Lee SK; Wang Z; Cohen ML; Appleby BS; Cali I
Acta Neuropathol Commun; 2023 Aug; 11(1):141. PubMed ID: 37653534
[TBL] [Abstract][Full Text] [Related]
20. Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.
Parchi P; Cescatti M; Notari S; Schulz-Schaeffer WJ; Capellari S; Giese A; Zou WQ; Kretzschmar H; Ghetti B; Brown P
Brain; 2010 Oct; 133(10):3030-42. PubMed ID: 20823086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]